Related Experiment Videos
ST789: a new synthetic immunomodulator.
1Cattedra Malattie Infettive, Dipartimento di Medicina Sperimentale, L'Aquila, Italy.
Thymus
|January 1, 1992
Summary
ST 789, a novel hypoxanthine derivative, demonstrates significant immunomodulant properties. Its structure, featuring an arginine component, enhances immune system activity, offering potential therapeutic benefits.
Area of Science:
- Immunology and Medicinal Chemistry
Background:
- Hypoxanthine derivatives are known for their immunomodulatory effects.
- Arginine incorporation into molecules can significantly boost immunomodulatory activity.
Purpose of the Study:
- To review the immunomodulatory properties of arginine and related compounds.
- To focus on the immunomodulatory potential of the synthetic compound ST 789.
Main Methods:
- Literature review of immunomodulatory compounds.
- Analysis of structure-activity relationships in hypoxanthine derivatives.
Main Results:
- ST 789 belongs to a new class of hypoxanthine derivatives.
- The N-9 position of the purine ring features an aminoacidic function.
- Arginine-containing compounds show enhanced immunomodulatory activity.
Conclusions:
- ST 789 possesses notable immunomodulatory properties.
- The compound's structure, including the arginine moiety, is key to its enhanced activity.
- Further research into ST 789 is warranted for its therapeutic potential.